CME Group (CME, Financial Exchanges & Data) Stock Valuation & Fair Value Trading above fair value
CME Group (CME, Financial Exchanges & Data) trades at a blended P/E of 20.5 — about 23% below its historical normal valuation — with a forward growth estimate of 7.0% and a PEG of 2.95. Analysts' one-year estimates have been hit 73% of the time.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been trading above fair value since 2026-06-03.
Frequently asked questions
Is CME Group stock overvalued?
At a blended P/E of 20.5 versus its historical normal P/E of 26.5, CME Group trades about 23% below its typical valuation, with a PEG of 2.95 on 7.0% forward growth — tickerseer currently rates it trading above fair value.
What is CME Group's fair value and PEG?
CME Group trades at a blended P/E of 20.5 against a historical normal P/E of 26.5, a PEG of 2.95, and a forward growth estimate of 7.0%.
Has tickerseer's rating of CME Group changed?
tickerseer's rating has been trading above fair value since 2026-06-03.
Industry: Financial Exchanges & Data. Create a free account to unlock the full analysis — the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.